{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T20:33:30Z","timestamp":1793306010698,"version":"4.5.0"},"reference-count":8,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","msard-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1016\/j.msard.2016.05.004","type":"journal-article","created":{"date-parts":[[2016,5,2]],"date-time":"2016-05-02T13:16:58Z","timestamp":1462195018000},"page":"64-65","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Refractory trigeminal neuralgia responsive to nabiximols in a patient with multiple sclerosis"],"prefix":"10.1016","volume":"8","author":[{"given":"Alberto","family":"Gajofatto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.msard.2016.05.004_bib1","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.pain.2012.12.002","article-title":"Prevalence and natural history of pain in adults with multiple sclerosis: systematic review and meta-analysis","volume":"154","author":"Foley","year":"2013","journal-title":"Pain"},{"key":"10.1016\/j.msard.2016.05.004_bib2","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1212\/WNL.0000000000000363","article-title":"Systematic review: efficacy and safety of medical marijuana in selected neurologic disorders: report of the guideline development subcommittee of the American Academy of Neurology","volume":"82","author":"Koppel","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2016.05.004_bib3","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1113\/jphysiol.2003.056986","article-title":"Cannabinoid-induced presynaptic inhibition at the primary afferent trigeminal synapse of juvenile rat brainstem slices","volume":"555","author":"Liang","year":"2004","journal-title":"J. Physiol."},{"key":"10.1016\/j.msard.2016.05.004_bib4","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.biocel.2014.08.007","article-title":"Neuropathic orofacial pain: cannabinoids as a therapeutic avenue","volume":"55","author":"McDonough","year":"2014","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.msard.2016.05.004_bib5","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1177\/1352458511419700","article-title":"A placebo-controlled, parallel- group, randomized withdrawal study of subjects with symptoms of spasticity due to multiple sclerosis who are receiving long-term Sativex\u00ae (nabiximols)","volume":"18","author":"Notcutt","year":"2012","journal-title":"Mult. Scler."},{"issue":"2","key":"10.1016\/j.msard.2016.05.004_bib6","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/ana.22366","article-title":"Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria","volume":"69","author":"Polman","year":"2011","journal-title":"Ann. Neurol."},{"issue":"12","key":"10.1016\/j.msard.2016.05.004_bib7","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1586\/14737175.2013.865877","article-title":"Advances in the management of multiple sclerosis spasticity: experiences from recent studies and everyday clinical practice","volume":"13","author":"Pozzilli","year":"2013","journal-title":"Expert Rev. Neurother."},{"key":"10.1016\/j.msard.2016.05.004_bib8","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1586\/ern.11.47","article-title":"THC and CBD oromucosal spray (Sativex\u00ae) in the management of spasticity associated with multiple sclerosis","volume":"11","author":"Sastre-Garriga","year":"2011","journal-title":"Expert Rev. Neurother."}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034816300566?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034816300566?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T08:39:19Z","timestamp":1761899959000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034816300566"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7]]},"references-count":8,"alternative-id":["S2211034816300566"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2016.05.004","relation":{},"ISSN":["2211-0348"],"issn-type":[{"value":"2211-0348","type":"print"}],"subject":[],"published":{"date-parts":[[2016,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Refractory trigeminal neuralgia responsive to nabiximols in a patient with multiple sclerosis","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2016.05.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}